Skip to content
  • Sunday, 26 July 2026
  • 2:53 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Scientists warn that current vitamin B12 guidelines may be putting your brain at risk
Neuroscience & Brain Research

Scientists warn that current vitamin B12 guidelines may be putting your brain at risk

Rifan Muazin May 22, 2026 0

The traditional understanding of Vitamin B12 has long centered on its essential role in DNA synthesis, the formation of red…

Read More
Clinical Diagnostics & Pathology

Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs

Reynand Amr Wu May 21, 2026 0

A groundbreaking longitudinal study, published on April 1, 2026, in Neurology Open Access, an official journal of the American Academy…

Read More
Clinical Diagnostics & Pathology

Higher Midlife Vitamin D Levels Linked to Lower Tau Protein Years Later, Offering New Insight for Neurodegenerative Disease Research

Reynand Amr Wu May 14, 2026 0

A groundbreaking longitudinal study, published on April 1, 2026, in Neurology Open Access, an official journal of the American Academy…

Read More
Pharmaceutical R&D

The Evolving Role of Vitamin E TPGS in Advanced Parenteral Drug Delivery

Teuku Ryan May 10, 2026 0

For decades, d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS), a derivative of vitamin E, has been a cornerstone in oral drug…

Read More
Clinical Diagnostics & Pathology

Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs

Reynand Amr Wu May 7, 2026 0

The persistent and growing global challenge of neurodegenerative diseases, particularly Alzheimer’s disease, has intensified the search for modifiable risk factors…

Read More
Clinical Diagnostics & Pathology

Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs

Reynand Amr Wu Apr 30, 2026 0

A landmark longitudinal study, published on April 1, 2026, in Neurology Open Access, an official journal of the American Academy…

Read More
Clinical Diagnostics & Pathology

Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs

Reynand Amr Wu Apr 22, 2026 0

A groundbreaking longitudinal study, published on April 1, 2026, in Neurology Open Access, an official journal of the American Academy…

Read More
Clinical Diagnostics & Pathology

Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs

Reynand Amr Wu Apr 15, 2026 0

A groundbreaking new longitudinal study, published April 1, 2026, in Neurology Open Access, an official journal of the American Academy…

Read More

Posts pagination

1 2
New Research Unveils Molecular Competition as Key Driver in Alzheimer’s Disease ProgressionUnlocking Ancient Secrets: New Study Reveals Deep Evolutionary Conservation of Regulatory DNA in PlantsLong-Term Residential Exposure to Chlorpyrifos Linked to Significant Increase in Parkinson’s Disease Risk According to New UCLA Health StudyUnlocking Python’s Dictionary Potential: Seven Advanced Techniques for Enhanced Code Clarity and Efficiency
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ